Senti Bio adjourns annual shareholder meeting to Oct. 15 to solicit merger votes
Senti Biosciences adjourned its virtual 2026 annual shareholder meeting without conducting business. Meeting pause aimed to allow more time to solicit votes supporting the merger agreement proposal outlined in the Sept. 24 proxy statement. Session will reconvene Oct. 15, 2026 at 8:00 a.m. Pacific time; quorum was prese